Company Orexigen Therapeutics, Inc. Nasdaq
Equities
US6861643020
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,887,033 | 18,887,033 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court Suite 200
92037, La Jolla
+858-875-8600
http://www.orexigen.comSector
1st Jan change | Capi. | |
---|---|---|
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |